PGI Chandigarh has been approved as one of the national centres by the Indian Council of Medical Research (ICMR) to conduct the trial of convalescent plasma therapy in patients with serious COVID-19 infection. ...
The safety trail of mycobacterial w (Mw) drug has been completed but its actual trial will be conducted on 40 patients in PGI Chandigarh and AIIMS-Delhi and Bhopal, said Dr Jagat Ram, Director of PGIMER, Chandigarh on Sunday. ...
PGI Chandigarh on Friday said it was not aware of study cited by Punjab Chief Minister Capt Amarinder Singh claiming 58 per cent of country's population could be COVID-19 infected by mid-September. ...